نتائج البحث - "Weight Loss -- drug effects"

1

كتاب

Obesity: epidemiology, pathophysiology, and prevention

المساهمون: Bagchi, Debasis., Preuss, Harry G., Bagchi, Debasis, 1954-

مصطلحات موضوعية: Obesity -- Epidemiology., Obesity -- Pathophysiology., Obesity -- therapy., Dietary Supplements., Obesity -- physiopathology., Weight Loss -- drug effects.

2

Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design

المؤلفون: Helen M. Colhoun, Scott S. Emerson, Steve Marso, G. Kees Hovingh, Kirstine Brown-Frandsen, Steven E. Kahn, John E. Deanfield, Robert F. Kushner, A. Michael Lincoff, Henrik Ravn, Jorge Plutzky, Ildiko Lingvay, Donna H. Ryan, Anders G. Holst, Marianne O. L. Gronning

المساهمون: Experimental Vascular Medicine, Vascular Medicine, ACS - Atherosclerosis & ischemic syndromes

المصدر: American heart journal, 229, 61-69. Mosby Inc.
Ryan, D H, Lingvay, I, Colhoun, H M, Deanfield, J, Emerson, S S, Kahn, S E, Kushner, R F, Marso, S, Plutzky, J, Brown-Frandsen, K, Gronning, M O L, Hovingh, G K, Holst, A G, Ravn, H & Lincoff, A M 2020, ' Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design ', American Heart Journal, vol. 229, pp. 61-69 . https://doi.org/10.1016/j.ahj.2020.07.008

مصطلحات موضوعية: Male, medicine.medical_specialty, Cardiotonic Agents, Heart disease, Weight Loss/drug effects, Population, Glucagon-Like Peptides, Glucagon-Like Peptides/administration & dosage, 030204 cardiovascular system & hematology, Overweight, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Glucagon-Like Peptide 1, Weight loss, Diabetes mellitus, Internal medicine, Outcome Assessment, Health Care, Weight Loss, medicine, Humans, Hypoglycemic Agents, Obesity, 030212 general & internal medicine, Risk factor, education, Randomized Controlled Trials as Topic, Cardiotonic Agents/administration & dosage, education.field_of_study, business.industry, Cardiovascular Diseases/epidemiology, Semaglutide, Obesity/diagnosis, Middle Aged, Hypoglycemic Agents/administration & dosage, medicine.disease, Overweight/diagnosis, Clinical Trials, Phase III as Topic, Cardiovascular Diseases, Heart Disease Risk Factors, Female, medicine.symptom, Glucagon-Like Peptide 1/agonists, Cardiology and Cardiovascular Medicine, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ddfd743696aa295b876c97fc2357306
https://doi.org/10.1016/j.ahj.2020.07.008

View record from ScienceDirect

Find this article in full text from ProQuest

Full Text via ClinicalKey

3

Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: The STEP 4 Randomized Clinical Trial

المؤلفون: Camilla B. Jensen, Sayeh Tadayon, Step Investigators, Niclas Abrahamsson, Dror Dicker, Frank L. Greenway, Dan Hesse, Gottfried Rudofsky, Melanie J. Davies, Julio Rosenstock, Ildiko Lingvay, Miguel A. Rubio, Thomas A. Wadden, Domenica Rubino, Ofri Mosenzon

المصدر: Rubino, D, Abrahamsson, N, Davies, M, Hesse, D, Greenway, F L, Jensen, C, Lingvay, I, Mosenzon, O, Rosenstock, J, Rubio, M A, Rudofsky, G, Tadayon, S, Wadden, T A, Dicker, D, Sjödin, A M & STEP 4 Investigators 2021, ' Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: The STEP 4 Randomized Clinical Trial ', JAMA, vol. 325, no. 14, pp. 1414-1425 . https://doi.org/10.1001/jama.2021.3224

مصطلحات موضوعية: Adult, Glucagon-Like Peptides/adverse effects, Male, medicine.medical_specialty, Obesity/drug therapy, Injections, Subcutaneous, Weight Loss/drug effects, Glucagon-Like Peptides, Blood Pressure, Overweight, Placebo, Blood Pressure/drug effects, law.invention, Waist Circumference/drug effects, Randomized controlled trial, Double-Blind Method, law, Weight loss, Glucagon-Like Peptide 1, Internal medicine, Weight Loss, medicine, Clinical endpoint, Anti-Obesity Agents/pharmacology, Humans, Overweight/drug therapy, Obesity, Maintenance dose, business.industry, Semaglutide, General Medicine, Middle Aged, Female, Anti-Obesity Agents, medicine.symptom, Waist Circumference, business, Glucagon-Like Peptide 1/agonists, Body mass index

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17ccf01a3b9760235ac5622c17a335a1
https://curis.ku.dk/ws/files/291012447/Rubino_et_al_JAMA_2021_Vol_325_14_1414_1425.pdf

4

رسالة جامعية

Very low energy diets in the treatment of obesity : studies of obstructive sleep apnoea, side-effects, and treatment discontinuation

المؤلفون: Johansson, Kari

مصطلحات موضوعية: Obesity -- complications, Obesity -- diet therapy, Obesity -- drug therapy, Diet, Reducing -- adverse effects, Energy Intake, Weight Loss -- drug effects, Gallstones -- etiology, Gallstones -- surgery, Sleep Apnea, Obstructive -- diet therapy, Sleep Apnea, Obstructive -- drug therapy, Sleep Apnea, Obstructive -- etiology, Anti-Obesity Agents -- adverse effects, Withholding Treatment

URL الوصول: http://hdl.handle.net/10616/40976

Degree: Diss. (sammanfattning) Stockholm : Karolinska institutet, 2012

5

Obésité : manger moins et bouger plus ? Pas si simple

المؤلفون: Correia, Jorge, Somers, Florence, Golay, Alain, Pataky, Zoltan

المصدر: Revue médicale suisse, Vol. 16, No 687 (2020) pp. 573-537

مصطلحات موضوعية: ddc:616, Anti-Obesity Agents / pharmacology, Education thérapeutique du patient, Exercise / physiology, Bariatric Surgery, Anti-Obesity Agents / therapeutic use, Exercise / psychology, Prise en charge multidisciplinaire, Activité physique, Weight Loss / drug effects, Humans, Obésité, Diet, Healthy, Obesity / prevention & control, Obesity / psychology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______1400::e945b3200cb25ca040a5ea5948067413
https://archive-ouverte.unige.ch/unige:136970

6

Pharmacological management of diabetes in severe mental illness: a comprehensive clinical review of efficacy, safety and tolerability

المؤلفون: Donal O’Shea, Aonghus O’ Loughlin, Allys Guerandel, Brendon Stubbs, John Lally, Fiona Gaughran

المصدر: Lally, J, O’ Loughlin, A, Stubbs, B, Guerandel, A, O’Shea, D & Gaughran, F 2018, ' Pharmacological management of diabetes in severe mental illness : a comprehensive clinical review of efficacy, safety and tolerability ', Expert review of clinical pharmacology, vol. 11, no. 4, pp. 411-424 . https://doi.org/10.1080/17512433.2018.1445968

مصطلحات موضوعية: medicine.medical_specialty, Psychosis, Diabetes Mellitus, Type 2/drug therapy, endocrine system diseases, Mental Disorders/physiopathology, Weight Loss/drug effects, education, Decision Making, Severity of Illness Index, Medication Adherence, 03 medical and health sciences, 0302 clinical medicine, Diabetes mellitus, Weight Loss, mental disorders, Severity of illness, Prevalence, medicine, Animals, Humans, Hypoglycemic Agents, Pharmacology (medical), 030212 general & internal medicine, General Pharmacology, Toxicology and Pharmaceutics, Intensive care medicine, business.industry, Mental Disorders, nutritional and metabolic diseases, Type 2 Diabetes Mellitus, General Medicine, Hypoglycemic Agents/administration & dosage, Mental illness, medicine.disease, Metformin, Diabetes Mellitus, Type 2, Tolerability, Schizophrenia, business, 030217 neurology & neurosurgery, medicine.drug